Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal VAsopressor TitraTION in Patients 65 Years and Older
Sponsor: Université de Sherbrooke
Summary
We have designed OVATION-65 to evaluate the effects of permissive low blood pressure compared to usual care on markers of organ injury and survival in older patients.
Official title: Optimal VAsopressor TitraTION in Patients 65 Years and Older (OVATION-65)
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
159
Start Date
2018-02-16
Completion Date
2024-12-31
Last Updated
2024-05-16
Healthy Volunteers
No
Interventions
MAP target 60-65 mmHg
Treating teams will adjust vasopressors to a target MAP range of 60 to 65 mmHg, avoiding vasopressor-induced MAP above this range.
Usual care
Patients in the control arm will receive usual care (as per local practices).
Locations (1)
CIUSSS de l'Estrie-CHUS
Sherbrooke, Quebec, Canada